Phytosomes containing quinine sulfate were prepared using the anti-solvent precipitation method, with six formulations (F1-F6) developed by varying quinine to soya lecithin ratios. Among these, formulation F3 exhibited superior characteristics, achieving an entrapment efficiency of 75.77% at a ratio of 1:3. Dissolution testing revealed enhanced drug release rates compared to pure quinine, with formulation F3 demonstrating the highest release (95.5%) within 120 minutes. Analysis of release kinetics indicated a first-order release pattern (R = 0.9956) and a diffusion-controlled mechanism (Higuchi model, R = 0.984). Fourier-transform infrared spectra confirmed the successful incorporation of quinine into phytosomes (F3) without chemical interaction or degradation, retaining characteristic peaks. These findings highlight formulation F3 as a promising candidate for further pharmacological investigation and therapeutic applications in enhancing quinine's bioavailability.
No takes yet. Share an insight, caveat, or question.
Kallah et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: